Minneapolis, Minnesota (PRWEB) November 29, 2011
In conjunction with The BioBusiness Alliance of Minnesota, Volkart May and Fortier Gruidl Associates recently presented to a delegation of Japanese companies interested in marketing their medical device products in the United States. The seminar focused on the importance of conducting upfront market research to guide major business decisions and case studies of companies who continued their research initiatives beyond early stages to generate better ROI on lead generation programs.
Volkart May specializes in gathering market intelligence and generating qualified sales leads and Fortier Gruidl Associates focuses on conducting qualitative market research studies. Both companies have a focus on life science and medical device industries and discussed best practices when marketing to physician offices, manufacturers and distributors.
One of the key points addressed was how to build and maintain a healthy sales pipeline through market research and how this sets the foundation for profitable lead generation and sales down the road.
Volkart May and Fortier Gruidl Associates talked about how to incorporate outbound market research and profiling calls to obtain qualitative and quantitative data as well as how to analyze and make decisions through the information captured.
“There are a lot of cultural differences to consider when marketing a product or service internationally,” said Chris Temperante, CEO/Partner for Volkart May. “This presentation sparked a lot of questions in the audience about the structure of sales and marketing departments in the U.S. versus in Japan and additional factors to consider when investing in an overseas strategy.”
About Volkart May: Volkart May is a B2B sales and marketing outsourcing partner that enables companies with high-value product and service solutions to increase sales force efficiency and grow their business by identifying more qualified sales opportunities. Volkart May specializes in making live, brand-enhancing lead generation and market research calls, securing sales appointments with decision makers, qualifying inquiries and building accurate, targeted marketing databases. For more information about our 21 years of healthcare, medical device, high tech and other industry experience, visit http://www.volkartmay.com.
About Fortier Gruidl Associates: Fortier Gruidl Associates is a research firm dedicated to providing its medtech industry clients with dependable healthcare market insight. From needs discovery, through R&D to product launch, our clients rely on us to help them formulate durable product development strategies founded on comprehensive knowledge of market drivers and clinician needs. Fortier Gruidl Associates works exclusively in the medtech arena and can quickly and intelligently tap key sources−including your customer base−to advance your product and business development decisions. For more information, visit http://www.fortiergruidlassociates.com.
About The BioBusiness Alliance of Minnesota: The BioBusiness Alliance of Minnesota is an industry-led, action-based 501(c) (3) not-for-profit organization dedicated to the advancement of bioscience-related industries to create jobs for the citizens of Minnesota. The charter of The BioBusiness Alliance of Minnesota is to bring together all related areas of the biosciences in a coordinated effort to help ensure the long-term health and success of Minnesota's bioscience industry. The organization has created a well-researched statewide roadmap and strategy, and is leading projects to implement its recommendations. For more information on the organization, contact Jeremy Lenz, The BioBusiness Alliance of Minnesota, 952-746-3812 jlenz(at)biobusinessalliance(dot)org http://www.BioBusinessAlliance.org.